Additionally, higher expression of CD133 was associated with poor differentiation and lymph node metastasis but there was no significant difference of CD133 expression between ADC and SCC in NSCLC patients. The gene discussed is PROM1; the disease is metastatic malignant neoplasm in the lymph nodes.